| 2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of … A Vahanian, F Beyersdorf, F Praz, M Milojevic, S Baldus, J Bauersachs, ... European heart journal 43 (7), 561-632, 2022 | 5417 | 2022 |
| ESC/EACTS Scientific Document Group, ESC National Cardiac Societies, 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the … A Vahanian, F Beyersdorf, F Praz, M Milojevic, S Baldus, J Bauersachs, ... Eur Heart J 43 (7), 561-632, 2022 | 464* | 2022 |
| Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis GCM Siontis, P Overtchouk, TJ Cahill, T Modine, B Prendergast, F Praz, ... European heart journal 40 (38), 3143-3153, 2019 | 441 | 2019 |
| Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials GCM Siontis, F Praz, T Pilgrim, D Mavridis, S Verma, G Salanti, ... European heart journal 37 (47), 3503-3512, 2016 | 416 | 2016 |
| Transcatheter versus medical treatment of patients with symptomatic severe tricuspid regurgitation M Taramasso, G Benfari, P van der Bijl, H Alessandrini, A Attinger-Toller, ... Journal of the American College of Cardiology 74 (24), 2998-3008, 2019 | 411 | 2019 |
| Outcomes after current transcatheter tricuspid valve intervention: mid-term results from the international TriValve registry M Taramasso, H Alessandrini, A Latib, M Asami, A Attinger-Toller, ... JACC: Cardiovascular Interventions 12 (2), 155-165, 2019 | 310 | 2019 |
| Imaging assessment of tricuspid regurgitation severity RT Hahn, JD Thomas, OK Khalique, JL Cavalcante, F Praz, WA Zoghbi JACC: Cardiovascular Imaging 12 (3), 469-490, 2019 | 264 | 2019 |
| Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man … F Praz, K Spargias, M Chrissoheris, L Büllesfeld, G Nickenig, F Deuschl, ... The Lancet 390 (10096), 773-780, 2017 | 251 | 2017 |
| Long-Term Propensity Score–Matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism A Wahl, P Jüni, ML Mono, B Kalesan, F Praz, L Geister, L Räber, ... Circulation 125 (6), 803-812, 2012 | 232 | 2012 |
| Transcatheter treatment for tricuspid valve disease: Transcatheter treatment for tricuspid valve disease F Praz, D Muraru, F Kreidel, P Lurz, RT Hahn, V Delgado, M Senni, ... EuroIntervention 17 (10), 791, 2021 | 222 | 2021 |
| Validation of Bleeding Risk Criteria (ARC-HBR) in Patients Undergoing Y Ueki, S Bär, S Losdat, T Otsuka, C Zanchin, T Zanchin, F Gragnano, ... Cardiol 66, 1036-1045, 2015 | 185* | 2015 |
| Effect of pulmonary hypertension hemodynamic presentation on clinical outcomes in patients with severe symptomatic aortic valve stenosis undergoing transcatheter aortic valve … CJ O’Sullivan, P Wenaweser, O Ceylan, J Rat-Wirtzler, S Stortecky, D Heg, ... Circulation: Cardiovascular Interventions 8 (7), e002358, 2015 | 178 | 2015 |
| Right ventricular-pulmonary arterial coupling and afterload reserve in patients undergoing transcatheter tricuspid valve repair MI Brener, P Lurz, J Hausleiter, J Rodés-Cabau, N Fam, SK Kodali, ... Journal of the American College of Cardiology 79 (5), 448-461, 2022 | 166 | 2022 |
| Transcatheter aortic valve replacement for the treatment of pure native aortic valve regurgitation: a systematic review A Franzone, R Piccolo, GCM Siontis, J Lanz, S Stortecky, F Praz, E Roost, ... Cardiovascular Interventions 9 (22), 2308-2317, 2016 | 147 | 2016 |
| Incidence and outcome of peri-procedural transcatheter heart valve embolization and migration: the TRAVEL registry (TranscatheteR HeArt Valve EmboLization and Migration) WK Kim, U Schäfer, D Tchetche, H Nef, M Arnold, P Avanzas, T Rudolph, ... European heart journal 40 (38), 3156-3165, 2019 | 144 | 2019 |
| Frequency, timing, and impact of access-site and non–access-site bleeding on mortality among patients undergoing transcatheter aortic valve replacement R Piccolo, T Pilgrim, A Franzone, M Valgimigli, A Haynes, M Asami, ... JACC: Cardiovascular Interventions 10 (14), 1436-1446, 2017 | 141 | 2017 |
| The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of … AJS Coats, SD Anker, A Baumbach, O Alfieri, RS von Bardeleben, ... European heart journal 42 (13), 1254-1269, 2021 | 138 | 2021 |
| Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk N Corpataux, A Spirito, F Gragnano, L Vaisnora, R Galea, S Svab, ... European heart journal 41 (38), 3743-3749, 2020 | 126 | 2020 |
| ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up Cardiovascular Research 118 (7), 1618-1666, 2022 | 120 | 2022 |
| Transcatheter tricuspid valve repair with a new transcatheter coaptation system for the treatment of severe tricuspid regurgitation: 1-year clinical and echocardiographic results G Perlman, F Praz, R Puri, H Ofek, J Ye, F Philippon, T Carrel, P Pibarot, ... JACC: Cardiovascular Interventions 10 (19), 1994-2003, 2017 | 116 | 2017 |
